First human trial begins for new eczema drug candidate
Disease control
Recruiting now
This is the first study in humans to test the safety and how the body processes a new drug called ATTO-3712. It will involve healthy adults and people with moderate-to-severe atopic dermatitis (eczema). Researchers will give increasing doses to see how well it's tolerated and how…
Phase: PHASE1 • Sponsor: Attovia Therapeutics Inc • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC